You are here

Vireo Health International Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
VREO
CSE Index: 
Currency: 

Vireo is one of America's leading multi-state cannabis companies. Vireo is a physician-led, science-focused organization, dedicated to providing patients with best-in-class quality cannabis-based products and customer experience. Vireo cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis extracts, and sells its products at both company-owned and third-party dispensaries. Vireo currently has operations in ten states: Arizona, Maryland, Massachusetts, Minnesota, Nevada, New Mexico, New York, Ohio, Pennsylvania and Rhode Island, plus Puerto Rico.

In addition to the listed Subordinate Voting Shares, there are 563,032 Multiple Voting Shares and 65,411 Super Voting Shares issued and outstanding.  Each Super Voting Share is convertible into one Multiple Voting Share at the option of the holder or upon certain triggering events. Each Multiple Voting Share is convertible into 100 Subordinate Voting Shares at the option of the holder or upon certain triggering events. This number also includes subordinate voting shares underlying existing and proposed convertible securities.

 

You are here

Vireo Health International Inc. (VREO)

SEDAR Information

Company Info

Address
2200, HSBC Building, 885 West Georgia Street
Vancouver, BC V6C 3E8
Canada
Email
investor@vireohealth.com
Website
https://vireohealth.com/
Listing date
Wednesday, March 20, 2019
Transfer Agent
Odyssey Trust Company
Investor Relations
Sam Gibbons
Email
investor@vireohealth.com
Auditor
Davidson & Company LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
24,312,854
Reserved for Issuance: 
87,661,938
Total equity shares, as if converted: 
111,974,792

Company Officers

Dr. Kyle Kingsley, Chairman and Chief Executive Officer
Bruce Linton, Executive Chairman
Amber Shimpa, Chief Financial Officer & Director
Aaron (Ari) Hoffnung, Chief Strategy Officer
Dr. Stephen Dahmer, Chief Medical Officer
Michael Schroeder, General Counsel, Chief Compliance Officer & Secretary

Bulletins

19/03/2019

2019-0319 – New Listing - Vireo Health International Inc. (VREO)

Le 19 mars/March 2019

The Subordinate Voting Shares of Vireo Health International, Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

11_18_Cannabis_Invest_UK_Website

Cannabis Invest UK

Monday, November 18, 2019 -
9:00am to 7:00pm
11-20_US_Cannabis_Regulatory_Update_-_Website

U.S. Cannabis Regulatory Update

Wednesday, November 20, 2019 -
3:00pm to 7:00pm